Search

everythinglearnresearchcommunity

for

Search:↓

Early-onset male baldness is significantly linked to metabolic syndrome, suggesting those with early baldness should consider preventive treatment to reduce risk.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.

People with early-onset hair loss have higher risk of heart issues, so early screening is important.

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

Men with certain patterns of hair loss, especially the U pattern, are more likely to develop insulin resistance.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Vertical sleeve gastrectomy improved metabolism, behavior, and reproduction in obese rats with PCOS.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

PCOS may be linked to spina bifida in young females.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

High levels of androgens during early development may cause PCOS-like symptoms.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

Duodenal mucosal resurfacing did not improve insulin sensitivity or reproductive function in women with PCOS.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

ARL15 is important for fat cell development and the release of the hormone adiponectin.